JFR: Radiologists, urologists, and patients collaborate for kidney tumor treatment - AuntMinnieEurope
JFR: Radiologists, urologists, and patients collaborate for kidney tumor treatment AuntMinnieEurope
Kidney Cancer News
Gene expression linked to survival differs by kidney cancer subtype - Medical Xpress
Gene expression linked to survival differs by kidney cancer subtype Medical Xpress
Merck, Eisai’s Welireg-Lenvima combo lands FDA nod to jump the kidney cancer queue - Fierce Pharma
Merck, Eisai’s Welireg-Lenvima combo lands FDA nod to jump the kidney cancer queue Fierce Pharma
How clear cell RCC diagnosis shapes treatment - Mayo Clinic Press
How clear cell RCC diagnosis shapes treatment Mayo Clinic Press
Gene expression linked to survival differs by kidney cancer subtype - EurekAlert! Science News Releases
Gene expression linked to survival differs by kidney cancer subtype EurekAlert! Science News Releases
Novel CAR T cell therapy offers promising option for hard-to-treat kidney cancer - UT MD Anderson
Novel CAR T cell therapy offers promising option for hard-to-treat kidney cancer UT MD Anderson
Aggressive Renal Cell Carcinoma Rising Among Young Adult Men - Renal and Urology News
Aggressive Renal Cell Carcinoma Rising Among Young Adult Men Renal and Urology News
FDA Approves Belzutifan + Lenvatinib for Clear Cell Kidney Cancer - Memorial Sloan Kettering Cancer Center
FDA Approves Belzutifan + Lenvatinib for Clear Cell Kidney Cancer Memorial Sloan Kettering Cancer Center
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer - Nature
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer Nature
Chromatin Loss Rewires Kidney Cancer Mitochondria, and an Old Drug Can Reverse It - Bioengineer.org
Chromatin Loss Rewires Kidney Cancer Mitochondria, and an Old Drug Can Reverse It Bioengineer.org
Warning Signs of Kidney Cancer You Shouldn’t Ignore - Fox Chase Cancer Center
Warning Signs of Kidney Cancer You Shouldn’t Ignore Fox Chase Cancer Center
FDA Approves Welireg Plus Lenvima for Advanced Kidney Cancer After Immunotherapy - Cure Today
FDA Approves Welireg Plus Lenvima for Advanced Kidney Cancer After Immunotherapy Cure Today
Novel Drug Shows Promise for Treating Advanced Kidney Cancer - Yale School of Medicine
Novel Drug Shows Promise for Treating Advanced Kidney Cancer Yale School of Medicine
FDA expands use of kidney cancer drug developed from UTSW research: Newsroom - UT Southwestern
FDA expands use of kidney cancer drug developed from UTSW research: Newsroom UT Southwestern
Figlin, Hendifar Named to New Cedars-Sinai Cancer Roles - Cedars-Sinai
Figlin, Hendifar Named to New Cedars-Sinai Cancer Roles Cedars-Sinai
FDA Approves Belzutifan-Lenvatinib Combo for Advanced Kidney Cancer - The American Journal of Managed Care
FDA Approves Belzutifan-Lenvatinib Combo for Advanced Kidney Cancer The American Journal of Managed Care
Cancer survivors find strength in community run - The Victoria Advocate
Cancer survivors find strength in community run The Victoria Advocate
Long-Term Outcomes With SABR in Primary Renal Cell Carcinoma - The ASCO Post
Long-Term Outcomes With SABR in Primary Renal Cell Carcinoma The ASCO Post
A disease-centric vision-language foundation model for precision oncology in kidney cancer - Nature
A disease-centric vision-language foundation model for precision oncology in kidney cancer Nature
Kidney Cancer in Young Adults: Rising Risks and the Truth About Symptoms - Cure Today
Kidney Cancer in Young Adults: Rising Risks and the Truth About Symptoms Cure Today
Stage 4 kidney cancer survivor thankful he chose UT MD Anderson for treatment - UT MD Anderson
Stage 4 kidney cancer survivor thankful he chose UT MD Anderson for treatment UT MD Anderson
Genetic landscape and functional exploration of kidney cancer predisposition in cross-ancestral populations - Nature
Genetic landscape and functional exploration of kidney cancer predisposition in cross-ancestral populations Nature
Nine Patients Received a Personalized Kidney Cancer Vaccine. None Had a Recurrence. - ScienceAlert
Nine Patients Received a Personalized Kidney Cancer Vaccine. None Had a Recurrence. ScienceAlert
Kidney Cancer Diagnoses Rise in Younger Adults, Expert Says - Cure Today
Kidney Cancer Diagnoses Rise in Younger Adults, Expert Says Cure Today
Review highlights how altered metabolism drives kidney cancer growth - News-Medical
Review highlights how altered metabolism drives kidney cancer growth News-Medical
Boy Diagnosed With Rare Kidney Cancer Before First Birthday Now Thriving After Treatment - Cleveland Clinic
Boy Diagnosed With Rare Kidney Cancer Before First Birthday Now Thriving After Treatment Cleveland Clinic
Personalized T-Cell Therapy Induces Complete Remission of Metastatic Kidney Cancer - Inside Precision Medicine
Personalized T-Cell Therapy Induces Complete Remission of Metastatic Kidney Cancer Inside Precision Medicine
Pembrolizumab Plus Denosumab Shows Activity in Pretreated Kidney Cancer - Targeted Oncology
Pembrolizumab Plus Denosumab Shows Activity in Pretreated Kidney Cancer Targeted Oncology
Sylvester Comprehensive Cancer Center Study Signals Novel Option for Hard-to-Treat Kidney Cancer - University of Miami
Sylvester Comprehensive Cancer Center Study Signals Novel Option for Hard-to-Treat Kidney Cancer University of Miami
Evolving Therapies Reshape Outcomes in Rare Kidney Cancer Subtypes - Physician's Weekly
Evolving Therapies Reshape Outcomes in Rare Kidney Cancer Subtypes Physician's Weekly
FDA Expands Merck's Welireg Label for a New Kidney Cancer Indication - Yahoo Finance
FDA Expands Merck's Welireg Label for a New Kidney Cancer Indication Yahoo Finance
Experimental drug combination shows early effectiveness in advanced kidney cancer - Mayo Clinic News Network
Experimental drug combination shows early effectiveness in advanced kidney cancer Mayo Clinic News Network
Statistical Rework Reveals Even Larger Survival Gain for Kidney Cancer Drug Combination - Bioengineer.org
Statistical Rework Reveals Even Larger Survival Gain for Kidney Cancer Drug Combination Bioengineer.org
Kidney cancer educational symposium, 'Hope in Motion: Empowering patients and caregivers,' is Aug. 21 - Vanderbilt Health News
Kidney cancer educational symposium, 'Hope in Motion: Empowering patients and caregivers,' is Aug. 21 Vanderbilt Health News
The Hidden Kidney Cancer: A Rare Threat to Young Athletes - Targeted Oncology
The Hidden Kidney Cancer: A Rare Threat to Young Athletes Targeted Oncology
World Kidney Cancer Day 2026 - Cancer Health
World Kidney Cancer Day 2026 Cancer Health
Darlifarnib Combo Shows Activity in Resistant Kidney Cancer - Cure Today
Darlifarnib Combo Shows Activity in Resistant Kidney Cancer Cure Today
New Frontiers in Kidney Cancer: Translating Discovery into Opportunity - American Association for Cancer Research
New Frontiers in Kidney Cancer: Translating Discovery into Opportunity American Association for Cancer Research
Advances in kidney cancer - Northside Hospital
Advances in kidney cancer Northside Hospital
Study Finds Investigational Drug Shows Promise in Advanced Kidney Cancer - UC San Diego Today
Study Finds Investigational Drug Shows Promise in Advanced Kidney Cancer UC San Diego Today